• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2002251 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2020-11-09 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG In Review 2020-11-07 view
CXHL1401462 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-04-07 view
CYHS2302419 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2023-09-08 GRAND Pharmaceutical (CHINA) Co Ltd view
JYHB2101027 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2021-04-10 view
JYHB1900562 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2019-05-22 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Certificate Issued 2019-07-17 view
JYHB2200023 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2022-01-14 view
JYHB2000592 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2020-05-15 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Filed 2020-05-26 view
CYHS2301611 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2023-06-13 Changzhou Pharmaceutical FACTORY view
JYHS2200071 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.2) Import Drug Application 2022-07-06 view
JYHB1800373 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2018-04-11 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Certificate Issued 2018-08-09 view
CYHS2402248 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2024-07-18 Zhejiang Wansheng Pharmaceutical Co Ltd view
JYHZ2200158 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs License Renew 2022-06-21 view
JXHL2000037 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Import Drug Application 2020-02-26 Novartis Pharmaceuticals Corporation Novartis Pharmaceuticals Corporation In Review 2020-02-25 view
JYHB2101477 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2021-10-21 view
CYHS2302373 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2023-09-05 view
JYHB2101478 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2021-10-21 view
JYHB1800798 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2018-07-20 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Certificate Issued 2018-09-04 view
JXHS2200043 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Import Drug Application 2022-05-24 view
JYHB2000526 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2020-04-29 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Filed 2020-05-12 view
CYHS2301530 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2023-06-05 Jewim Pharmaceutical (Shandong) Co Ltd view